Guillian Barre Syndrome Flashcards
1
Q
What is the pathophysiology behind GBS?
A
- Aka acute inflammatory demyelinating polyneuropathy (AIDP), the commonest type of GBS.
Pathophysiology
- Patchy demyelination of nerve roots though autoimmune T cell destruction.
- Due to molecular mimicry post infection.
2
Q
What causes GBS?
A
- URTI (1 in 2): CMV, EBV, Mycoplasma.
- Gastroenteritis: Campylobacter jejuni.
- Idiopathic (1 in 3).
- Rare causes: HIV seroconversion, possibly flu vaccine (but if so, extremely rare and benefits of vaccine far outweigh the risk).
3
Q
What is the time course of GBS?
A
- 2-4 week progressive phase, then recovery.
- Chronic inflammatory demyelinating polyneuropathy (CIDP) is its chronic counterpart, and the label applied when GBS symptoms fail to plateau and begin improvement within 8 weeks.
4
Q
What are the signs and symptoms of GBS?
A
- Typically presents around 2-4 weeks post infection.
Ascending motor and sensory symptoms:
- Starts with distal paraesthesia and proximal weakness.
- Limbs are first affected. Usually starts with legs, but can be arms too.
- Proceeds to affect trunk, respiratory muscles, and cranial nerves (especially CN7).
- Usually symmetrical.
- Other features:
- ↓Reflexes (95%).
- Pain: back, limb.
- Autonomic symptoms: ↓sweating, arrhythmias especially ↑HR, ↑BP or ↓BP, ileus.
- 15% have a descending pattern e.g. cranial nerves affected first.
- AIDP is the commonest type. Other variants are:
- Miller Fischer syndrome: descending paralysis. Triad of ophthalmoplegia, ataxia (limb/gait), and areflexia. Anti-GQ1b Ab +ve.
- Acute motor sensory axonal neuropathy: acute quadriparesis, areflexia, distal sensory loss, and respiratory insufficiency. Poor recovery.
- Acute motor axonal neuropathy: symmetrical limb weakness, areflexia, and face weakness. Commoner in China.
- DDx: Acute neurogenic ventilatory failure
- Guillain-Barré syndrome.
- Myasthenia gravis.
- Polymyositis
- MND
- Botulism
- Polio
5
Q
Which investigations should be done in suspected GBS?
A
- Bloods:
- U+E: SIADH may occur in up to 50%, likely due to dysautonomia.
- LFT: occasionally ↑ALT and ↑AST (mechanism unclear).
- Peripheral and central nervous system Ab screen.
- Consider stool culture to check for recent C. jejuni infection.
Special tests:
- Nerve conduction studies are the key diagnostic test, showing slowed conduction. 95% sensitive.
- LP: ↑protein. Often normal in first week, so its use early on is mainly to exclude other diagnoses.
- Spirometry: carry out regularly to look for signs of respiratory compromise (↓FVC).
- Imaging:
- MRI to rule out other causes e.g. disc problem.
- ECG: may show arrhythmias, heart block.
6
Q
How is GBS managed?
A
- Supportive treatment, including HR and BP control. In some cases this is sufficient.
- IVIg or plasma exchange, especially if severe (e.g. non-ambulatory).
- ITU transfer if ↓FVC.
- DVT prophylaxis.
- There is little evidence for steroids.
- Intravenous immunoglobulin (IVIg)
Pooled IgG of >1000 donors.
Mechanism
Unclear, but may include:
- Neutralises cytokines.
- Modulates Fc receptor-mediated phagocytosis.
- Stimulates complement removal of all Ab including host auto-Ab.
7
Q
What are the side-effects of intravenous immunoglobulin?
A
- Infection from donors.
* Anaphylaxis if IgA deficient. Plasma exchange is an alternative for these patients.
8
Q
What is the prognosis for GBS?
A
- 80% recover, including those who become fully paralysed.
- 10% can’t walk at 1 year.
- 10% mortality.